Japan Tobacco Cuts Its Pharmaceutical-related R&D Spending (Japan)
This article was originally published in PharmAsia News
Executive Summary
Japan Tobacco (JT) cut its pharmaceutical-related research and development spending by nearly 50 percent between 2002 and 2006. JT spent 19.3 billion yen in pharmaceutical-related research and development for the fiscal year ending in March 2006. This is far below 34.5 billion yen spent for the year extending from March 2001 to March 2002. The Japanese government is considering a ban on all smoking in public places as a health measure. However, they have been lackluster in their anti-smoking campaign to date. JT is a private company that is 50 percent owned by Japan's Finance Ministry, and JT has a legal monopoly on tobacco manufacturing in Japan. (Click here for more